Kotak Equities is optimistic on Indian pharma despite US tariff uncertainties; Sun Pharma, Lupin, Cipla among top picks | Stock Market News

In light of uncertainties surrounding US tariffs on pharmaceuticals, Kotak Institutional Equities noted in a recent…

Kotak stays cautious on India, sees limited value despite stock market crash | Stock Market News

The sharp downturn in the Indian stock markets over the last few months has failed to…

JSW Steel expects H2 turnaround after imports wash out Q2 margins | Company Business News

Mumbai: JSW Steel expects its margins to improve in the second half of FY25 as steel…

Several PSUs trade at extremely high market caps relative to their profits, net worth or assets: Kotak report | Stock Market News

The Indian equity markets have experienced a recent pullback following a record-breaking rally. In a recent…

Reliance Q1 results preview: Consolidated EBITDA may decline sequentially; Retail, Jio may stay strong | Mint

Reliance Q1 results preview: Reliance Industries (RIL) is expected to report a sequential decline in EBITDA…

HCL Tech Q1 preview: IT major may post weak revenue, EBIT margin likely to decline | Mint

The earnings season has finally kickstarted with Tata Consultancy Services (TCS) among first IT companies to…

104 cos with above 50x PE! Kotak warns of high P/E multiples in Indian market

The Indian equity market appears to be exhibiting a sense of benevolence or complacency, as fundamental…

FPIs Sold Equities Worth Rs 27,000 Crore In January

New Delhi: FPIs continued to be sellers in the cash market having sold equity worth Rs…

HCLT Q3 Result Preview: IT major likely to outshine peers with 4.8% QoQ growth

Shiv Nadar-led IT major HCL Tech is all set to announce its third quarterly results for…

Specialty chemical sector companies to witness another weak quarter, say analyst

Chemical intermediate makers and crop-protection chemical companies in India are likely to report a week third…